BioSig Technologies, Inc. STEX Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Liquidity | ||||||
| Current ratio | 13.9×+11.5× | 1.7×+1.5× | 0.1×-0.4× | 0×-0.8× | 2.4×+2.2× | |
| Per Share | ||||||
| Book value per share | $0.91+627% | $2.78+2,624% | -$0.21-735% | -$0.13-26,000% | $0.13+129% | |
| Valuation | ||||||
| Market capitalization | $88.66M-61.8% | $123.64M+381% | $203.16M+4,526% | $1.13B+24,967% | $14.31M+132% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are BioSig Technologies, Inc.'s profit margins?
- BioSig Technologies, Inc. (STEX) runs a 80.1% gross margin and a -32155.0% operating margin, with a -25825.0% net margin.
- Where do BioSig Technologies, Inc.'s ratios come from?
- Every ratio is computed from BioSig Technologies, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
